beta 2 glycoprotein 1 – igg

Assay is designed for the quantitative measurement of IgG class antibodies directed against the ß2-Glycoprotein 1. This test aids in determining the risk of primary and secondary Antiphospholipid Syndrome (APS). It also helps in monitoring the production of autoantibodies if individual is suffering from autoimmune disorder, such as lupus.